Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis — Stella

Recruiting

Back to Gastritis trials

Trial locations(1 site)

South Korea

Masong Kim Internal Medicine Clinic, Seoul

Key details

Sponsor

Daewoong Pharmaceutical Co. LTD.

Enrollment target

~12,000 participants

Started

June 2025

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years – 75 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov